Table 2.
Prevalence of reported symptoms after vaccination for SARS COV-2 at Adama, Ethiopia, 2021. (N=540)
| Variable | No | % | |
| Local side effects | Injection site pain | 346 | 64.1 |
| Injection site redness | 43 | 8 | |
| Injection site swelling | 31 | 5.7 | |
| Systemic side effects | Fatigue | 193 | 35.7 |
| Headache | 156 | 28.9 | |
| Joint pain | 143 | 26.5 | |
| Muscle pain | 116 | 21.5 | |
| Fever | 93 | 17.2 | |
| Chills | 47 | 8.7 | |
| Nausea | 36 | 6.7 | |
| Lack of sleep | 36 | 6.7 | |
| Vomiting | 14 | 2.6 | |
| Oro-pharyngeal pain | 13 | 2.4 | |
| Cough | 11 | 2 | |
| Back pain | 7 | 1.3 | |
| Skin rash | 3 | 0.6 | |
| Diarrhea | 3 | 0.6 | |
| Abdominal pain | 3 | 0.6 |